Platelets & Plasma

• Isola H, Brandner D, Stahl E et al.  Monitoring photochemical pathogen inactivation treatment using amotosalen and ultraviolet-A light:  Evaluation of an indicator label.  Vox Sang 2010;99(4):402.
  > View Vox Sang citation

Platelets

• Infanti L, Job S, Stebler D et al.  Pathogen-inactivation of platelet components with the INTERCEPT Blood System:  the first Swiss experience.  Transfusion and Apheresis Science 2011;(Oct);45(2):175-181.
   
• Isola H, Kientz D, Aleil B et al.  In vitro evaluation of Haemonetics MCS+ apheresis platelet concentrates treated with photochemical pathogen inactivation following plasma volume reduction using the INTERCEPT preparation set.  Vox Sang 2006;90(2):128-30.
  > View abstract
   
• Janetzko K, Lin L, Eichler H et al.  Implementation of the INTERCEPT Blood System for platelets into routine blood bank manufacturing procedures:  evaluation of apheresis platelets.  Vox Sang 2004;86(4):239-45.
  > View abstract
   
• Moog R, Frohlich A, Mayaudon V, Lin L.  In vitro evaluation of COM.TEC apheresis platelet concentrates using a preparation set and pathogen inactivation over a storage period of five days.  J Clin Apheresis 2004;19(4):185-91.
  > View abstract
   
• Picker SM, Speer R, Gathof BS.  Evaluation of processing characteristics of photochemically treated pooled platelets:  target requirements for the INTERCEPT Blood System comply with routine use after process optimization.  Transfus Med 2004;14(3):217-23.
  > View abstract